Given the scarce reports of UCHL members, excluding BAP1, in renal cancer, and our established connections between them from various perspectives, we aimed to assess the potential of UCHLs for RCC prognosis indicators, especially with a liquid biopsy, which is easier to perform, non-invasive, and faster than the traditional tissue biopsy. This evidence concerns the gene BAP1 and renal cell adenocarcinoma.